CVS Health (CVS) 2Q17 Results: Beats Consensus, Narrows Guidance Range

Executive Summary

• CVS Health reported 2Q17 adjusted EPS of $1.33, up 0.7% year over year and beating the $1.31 consensus estimate. Revenues were $45.7 billion, up 4.5% year over year, beating the $45.35 billion consensus estimate.
• Pharmacy Services was the fastest-growing segment, with revenues up 9.5% year over year, to $32.3 billion. Revenues in the Retail/LTC (Long-Term Care) segment declined by 2.2%.
• The company narrowed its 2017 adjusted EPS guidance range upward,to $5.83–$5.93 from $5.77–$5.93.